Eden Research plc Provides Revenue Guidance for the Half Year Ended 30 June 2022 and Full Year of 2022
For full year, the company revenue is expected to be on track to meet full year guidance of £1.4 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.54 GBX | +4.37% | +13.50% | -21.05% |
06-24 | Eden Research flagship biofungicide granted new authorisation in Spain | AN |
06-24 | Eden Research plc Announces Biofungicide Label Extension in Spain | CI |
1st Jan change | Capi. | |
---|---|---|
-21.05% | 29.29M | |
+11.94% | 37.39B | |
-.--% | 11.72B | |
+21.13% | 7.8B | |
-9.96% | 7.09B | |
+9.55% | 6.85B | |
-10.18% | 5.62B | |
-12.27% | 5.24B | |
-3.79% | 5.13B | |
+28.14% | 5.05B |